- Home
- MDAI vs LVTX Comparison
MDAI vs LVTX Comparison
Compare MDAI & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- LVTX
- Stock Information
- Founded
- MDAI 2013
- LVTX 2016
- Country
- MDAI United States
- LVTX Netherlands
- Employees
- MDAI 78
- LVTX N/A
- Industry
- MDAI Medical/Dental Instruments
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- LVTX Health Care
- Exchange
- MDAI Nasdaq
- LVTX Nasdaq
- Market Cap
- MDAI 33.1M
- LVTX 30.0M
- IPO Year
- MDAI N/A
- LVTX 2021
- Fundamental
- Price
- MDAI $1.21
- LVTX $1.29
- Analyst Decision
- MDAI Strong Buy
- LVTX Hold
- Analyst Count
- MDAI 2
- LVTX 3
- Target Price
- MDAI $4.75
- LVTX $3.17
- AVG Volume (30 Days)
- MDAI 149.5K
- LVTX 52.2K
- Earning Date
- MDAI 05-13-2025
- LVTX 05-20-2025
- Dividend Yield
- MDAI N/A
- LVTX N/A
- EPS Growth
- MDAI N/A
- LVTX N/A
- EPS
- MDAI N/A
- LVTX N/A
- Revenue
- MDAI $29,581,000.00
- LVTX $11,982,000.00
- Revenue This Year
- MDAI N/A
- LVTX N/A
- Revenue Next Year
- MDAI $102.58
- LVTX N/A
- P/E Ratio
- MDAI N/A
- LVTX N/A
- Revenue Growth
- MDAI 63.83
- LVTX 77.01
- 52 Week Low
- MDAI $0.82
- LVTX $0.85
- 52 Week High
- MDAI $3.25
- LVTX $3.20
- Technical
- Relative Strength Index (RSI)
- MDAI 40.42
- LVTX 47.92
- Support Level
- MDAI $1.25
- LVTX $1.17
- Resistance Level
- MDAI $1.32
- LVTX $1.37
- Average True Range (ATR)
- MDAI 0.05
- LVTX 0.08
- MACD
- MDAI 0.00
- LVTX -0.01
- Stochastic Oscillator
- MDAI 28.57
- LVTX 22.43
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.